Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-01-13 Sale | 2023-01-18 5:58 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $37.18 | $1,078,261 | 558,853 (Direct) | View |
2023-01-09 Sale | 2023-01-11 7:09 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $34.82 | $2,089,472 | 639,377 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-08 Option Award | 2023-02-10 4:54 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 108,000 | $0 | 108,000 (Direct) | View |
2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $23.03 | 558,853 (Direct) | View |
2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $0 | 558,853 (Direct) | View |
2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $23.03 | 639,377 (Direct) | View |
2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $0 | 639,377 (Direct) | View |
2022-02-02 Option Award | 2022-02-03 6:13 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
2021-01-18 Option Award | 2021-01-21 7:33 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 356,000 | $0 | 356,000 (Direct) | View |